Literature DB >> 6740847

Subcapsular orchiectomy with intracapsular testicular prosthesis for metastatic prostate carcinoma.

K L Short, L W Howerton, H Holt, M Amin.   

Abstract

Fifteen patients underwent subcapsular orchiectomy with placement of an intracapsular testicular prosthesis for hormonal treatment of symptomatic Stage D carcinoma of the prostate. Serum testosterone decreased to castration levels, and the intracapsular prosthesis was often indistinguishable from a normal testicle postoperatively. This new technique of castration may be considered an alternative in those patients reluctant to undergo other forms of orchiectomy.

Entities:  

Mesh:

Year:  1984        PMID: 6740847     DOI: 10.1016/0090-4295(84)90384-4

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  5 in total

1.  The cost and availability of therapeutic options in advanced prostatic carcinoma in Turkey.

Authors:  N Y Ilker; O Dillioğlugil; A Akdaş
Journal:  Int Urol Nephrol       Date:  1992       Impact factor: 2.370

Review 2.  Testicular prostheses: development and modern usage.

Authors:  D Bodiwala; D J Summerton; T R Terry
Journal:  Ann R Coll Surg Engl       Date:  2007-05       Impact factor: 1.891

3.  Can Subepididymal Orchiectomy Re-emerge as the Treatment of Choice in Patients with Advanced Prostatic Carcinoma?

Authors:  Mayank Agarwal; Madhu Sudan Agrawal
Journal:  Indian J Surg       Date:  2012-09-18       Impact factor: 0.656

4.  Prospective randomised controlled trial comparing sub-epididymal orchiectomy versus conventional orchiectomy in metastatic carcinoma of prostate.

Authors:  Shivadeo Bapat; Pratikshit M Mahajan; Ashish A Bhave; Yogesh B Kshirsagar; Yogesh B Sovani; Abhirudra Mulay
Journal:  Indian J Surg       Date:  2011-02-01       Impact factor: 0.656

5.  Satisfaction and genital perception after orchiectomy for prostate cancer: does the technique matter? A randomized trial.

Authors:  Onkar Singh; Partho Mukherjee; M S Sakthivel; Cornerstone Wann; A J P George; Rajesh Gopalakrishnan; Belavendra Antonisamy; Antony Devasia; Santosh Kumar; Nitin S Kekre; J Chandrasingh
Journal:  Int Urol Nephrol       Date:  2021-04-13       Impact factor: 2.370

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.